KEMPHARM, INC (KMPH) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 196 transactions totaling $9.3M, demonstrating a bullish sentiment with $9.3M in net insider flow. The most recent transaction on Jan 13, 2023 involved a purchase of 9,500 shares valued at $51.7K.
No significant insider buying has been recorded for KMPH in the recent period.
No significant insider selling has been recorded for KMPH in the recent period.
Based on recent SEC filings, insider sentiment for KMPH is bullish with an Insider Alignment Score of 100/100 and a net flow of $9.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at KEMPHARM, INC (KMPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading KMPH stock, having executed 196 transactions in the past 90 days. The most active insider is Street Capital Master Fund, L.p. Delaware (Executive), who has made 4 transactions totaling $7.1M.
Get notified when executives and directors at KMPH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 13, 2023 | W. Pascoe Richard | Executive | Purchase | 9,500 | $5.44 | $51.7K | |
| Jan 13, 2023 | Laduane Clifton R. | Executive | Purchase | 25 | $5.59 | $140 | |
| Jan 13, 2023 | Laduane Clifton R. | Executive | Purchase | 610 | $5.82 | $3.6K | |
| Sep 30, 2022 | Laduane Clifton R. | Executive | Purchase | 600 | $5.98 | $3.6K | |
| Sep 30, 2022 | Laduane Clifton R. | Executive | Purchase | 400 | $5.98 | $2.4K | |
| May 25, 2022 | C. Mickle Travis | Executive | Purchase | 2,000 | $4.36 | $8.7K | |
| May 25, 2022 | C. Mickle Travis | Executive | Purchase | 10,000 | $4.39 | $43.9K | |
| May 25, 2022 | C. Mickle Travis | Executive | Purchase | 1,000 | $4.39 | $4.4K | |
| May 25, 2022 | S. Tierney David | Executive | Purchase | 2,000 | $4.39 | $8.8K | |
| May 20, 2022 | A. Seymour Tamara | Executive | Purchase | 200 | $4.87 | $974 | |
| May 18, 2022 | Laduane Clifton R. | Executive | Purchase | 1,200 | $5.00 | $6.0K | |
| May 18, 2022 | W. Pascoe Richard | Executive | Purchase | 333 | $4.94 | $1.6K | |
| May 18, 2022 | W. Pascoe Richard | Executive | Purchase | 400 | $4.91 | $2.0K | |
| May 18, 2022 | W. Pascoe Richard | Executive | Purchase | 400 | $4.91 | $2.0K | |
| May 18, 2022 | W. Pascoe Richard | Executive | Purchase | 1,767 | $4.92 | $8.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 132 | $9.3M | 98.1% |
Exercise(M) | 2 | $77.5K | 0.8% |
Exercise (Options)(X) | 4 | $64.7K | 0.7% |
Award(A) | 11 | $21.1K | 0.2% |
Payment(F) | 1 | $15.5K | 0.2% |
Other(J) | 8 | $0 | 0.0% |
Gift(G) | 27 | $0 | 0.0% |
Conversion(C) | 11 | $0 | 0.0% |
Insiders at KEMPHARM, INC are accumulating shares at an accelerated pace. With 16 insiders making 196 transactions totaling $9.3M in purchases versus $0 in sales, the net buying activity of $9.3M signals strong executive confidence. Street Capital Master Fund, L.p. Delaware (Executive) leads the buying activity with $7.1M in transactions across all time.